Ieq Capital LLC Acquires Shares of 213,233 Danaher Corporation $DHR

Ieq Capital LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 213,233 shares of the conglomerate’s stock, valued at approximately $153,536,000. Danaher makes up about 0.7% of Ieq Capital LLC’s holdings, making the stock its 19th biggest holding.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. increased its stake in shares of Danaher by 303.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Puzo Michael J bought a new stake in shares of Danaher in the 2nd quarter worth approximately $8,624,000. Legal & General Group Plc lifted its stake in Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after purchasing an additional 43,169 shares during the last quarter. Handelsbanken Fonder AB grew its holdings in Danaher by 10.9% during the second quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after purchasing an additional 28,425 shares during the period. Finally, Advisors Capital Management LLC grew its holdings in Danaher by 14.0% during the fourth quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after purchasing an additional 6,720 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.6%

Shares of DHR stock opened at $219.42 on Friday. The stock has a market capitalization of $154.25 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. The company’s fifty day simple moving average is $195.80 and its two-hundred day simple moving average is $192.61. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the company earned $0.77 earnings per share. As a group, analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on DHR. Argus lowered their target price on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Guggenheim cut their price target on Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. TD Cowen decreased their price objective on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Weiss Ratings upgraded Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Finally, Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.